Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ICG-136 by ICell Gene Therapeutics for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
ICG-136 is under clinical development by ICell Gene Therapeutics and currently in Phase I for Acute Myelocytic Leukemia (AML, Acute...